Ticker

Totaligent's (OTCID: TGNT) President participated in the Uncharted Impact x A-Team Hub Accelerator U.S.–Taiwan innovation forum, hosted at Warner Brothers

BOCA RATON, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT) (“Totaligent” or “the Company”), today announced the formation of a 50/50 joint venture between its wholly owned subsidiary, Aetherium Medical LLC, and GloMed Solutions Limited Liability Company (“GloMed”), a Japanese company with a proven distribution network in the Asia-Pacific region.

BOCA RATON, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT) (“Totaligent” or “the Company”), an emerging leader in specialized infrastructure platform for the blossoming biologics space and intelligent business marketing data, today announced the successful closing of the previously announced Definitive Agreement with Ivan Klarich, founder of Aetherium Medical, for the strategic acqui-hire of…

BOCA RATON, Fla. , May 20, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT) ("Totaligent" or "the Company"), an emerging leader in specialized infrastructure platform for the blossoming biologics space and intelligent business marketing data, today announced the successful closing of the previously announced Definitive Agreement with Ivan Klarich, founder of Aetherium Medical, for the strategic acqui-hire of…

BOCA RATON, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT) (“Totaligent” or “the Company”), an emerging leader in specialized infrastructure platform for the blossoming biologics space and intelligent business marketing data, today announced the strategic commercial positioning of its soon to be acquired Aetherium Medical platform as a direct response to one of the most significant structural…